Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
about
Profile of nivolumab in the treatment of metastatic squamous non-small-cell lung cancerA phase I study of nedaplatin, pemetrexed and thoracic intensity-modulated radiotherapy for inoperable stage III lung adenocarcinomaGLUT1-mediated selective tumor targeting with fluorine containing platinum(II) glycoconjugatesThe role of docetaxel in the treatment of non-small cell lung cancer lung cancer: an update.Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.Platinum-Based Adjuvant Chemotherapy for Stage II and Stage III Squamous Cell Carcinoma of the Lung.Investigational therapies for squamous cell lung cancer: from animal studies to phase II trials.Efficacy of short-term nivolumab treatment in a Chinese patient with relapsed advanced-stage lung squamous cell carcinoma: A case reportMeta-analysis comparing the efficacy of nedaplatin-based regimens between squamous cell and non-squamous cell lung cancers.Nedaplatin as a Single-Agent Chemotherapy May Support Palliative Therapy for Patients with Adenoid Cystic Carcinoma: A Case Report.The best platinum regimens for chemo-naive incurable non-small cell lung cancer: network meta-analysis.RNA-sequencing dissects the transcriptome of polyploid cancer cells that are resistant to combined treatments of cisplatin with paclitaxel and docetaxel.Incidence of and risk factors associated with nedaplatin-related hypersensitivity reactions.Phase I study of Nedaplatin, a platinum based antineoplastic drug, combined with nab-paclitaxel in patients with advanced squamous non-small cell lung cancer.Evaluating the significance of density, localization, and PD-1/PD-L1 immunopositivity of mononuclear cells in the clinical course of lung adenocarcinoma patients with brain metastasis.Phase II study of nedaplatin and irinotecan as adjuvant chemotherapy for completely resected non-small cell lung cancer.Novel chemotherapy regimens for advanced lung cancer: have we reached a plateau?Breakthroughs in the treatment of advanced squamous-cell NSCLC: not the neglected sibling anymore?Miltirone-induced apoptosis in cisplatin-resistant lung cancer cells through upregulation of p53 signaling pathways.
P2860
Q26745590-C77BEA4F-609B-4CA4-B1B1-7CB7F15BD524Q33435839-EE546EA7-D000-4EE8-A7F7-7BB439A226B5Q33889236-C2BC2DA7-D1C5-4296-BD4D-CB4ACCD27ED2Q36142491-C9CD483F-8660-4EED-AF1B-85725186E0F8Q37233557-75D0B646-7610-4A06-8396-A51A6609694DQ37695838-25F42B9C-174E-4932-B221-2B63DCE7C89AQ38748140-FAA2ACD9-F4B7-48CD-B445-CCB882652274Q41425693-9E775AB1-3861-4C1C-AAE4-F579E67AF7FBQ42365337-5ADFCC1A-F124-44A2-A180-1FFBC3E26C92Q42365695-292A8A5C-9011-4D3D-8ED9-1D233DB190D1Q42377257-2E65B224-60CF-4591-8E2C-266A797D123DQ42777412-5EC9AF0C-63E7-4397-A28A-4C4A9FF50ECDQ47576894-9340C75D-34B7-483E-A3C0-9389164057A8Q47903659-77CD30B7-FB23-4150-BCA8-8FA36019C836Q48307824-EAD70100-6897-4DBE-B0A2-CF65F60C5D9AQ50109053-384DCD57-6606-446B-B640-8B564ED8D911Q55115366-87CC3F8F-6AD9-4DF2-A82D-48A4BA584EF9Q55341383-85991BDC-A3A4-43C9-854A-6B5D904C7338Q55347991-22579E68-4BC9-450B-A704-219EBE5DECF5
P2860
Nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell carcinoma of the lung (WJOG5208L): a randomised, open-label, phase 3 trial.
description
2015 nî lūn-bûn
@nan
2015 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Nedaplatin plus docetaxel vers ...... ed, open-label, phase 3 trial.
@ast
Nedaplatin plus docetaxel vers ...... ed, open-label, phase 3 trial.
@en
type
label
Nedaplatin plus docetaxel vers ...... ed, open-label, phase 3 trial.
@ast
Nedaplatin plus docetaxel vers ...... ed, open-label, phase 3 trial.
@en
prefLabel
Nedaplatin plus docetaxel vers ...... ed, open-label, phase 3 trial.
@ast
Nedaplatin plus docetaxel vers ...... ed, open-label, phase 3 trial.
@en
P2093
P1433
P1476
Nedaplatin plus docetaxel vers ...... ed, open-label, phase 3 trial.
@en
P2093
Haruko Daga
Hideo Saka
Hiroyasu Kaneda
Kazuhiko Nakagawa
Koichi Goto
Nobuyuki Yamamoto
Seisuke Nagase
Shunichi Sugawara
Soichiro Yokota
Takashi Nishimura
P304
P356
10.1016/S1470-2045(15)00305-8
P577
2015-10-27T00:00:00Z